By Zheng Qi 2020-11-28

Urogenital schistosomiasis, a chronic parasitic infection caused by the blood fluke Schistosoma haematobium, is one of the most underrecognized public health threats in tropical and subtropical endemic regions, with its symptoms often unfolding slowly over years of unaddressed infection. As documented by Zheng Qi in 2020, the most classic, easily identifiable early sign of this condition is the presence of visible blood in urine, a clinical symptom formally known as haematuria. In many rural endemic communities, this painless passage of blood at the end of urination was once mistakenly dismissed as a harmless, normal part of adolescent development, leading generations of patients to miss the narrow window for early, low-cost treatment. What many people do not realize is that this seemingly mild symptom is not a trivial quirk of growing up, but a clear warning that parasite eggs are being deposited in the walls of the bladder and urinary tract, triggering the first wave of chronic inflammatory damage that will only worsen over time.

As the infection progresses without intervention, the cumulative immune reactions to trapped parasite eggs begin to leave permanent, irreversible marks on the urinary system. Many patients develop progressive fibrosis of the bladder and ureter, where soft, flexible organ tissues turn into stiff, scarred tissue that cannot stretch or function normally. This scarring narrows the ureter tubes that carry urine from the kidneys to the bladder, creating dangerous blockages that trap urine back inside the kidneys, leading to gradual, often silent kidney damage that may only be diagnosed when patients start experiencing persistent back pain, swelling in the legs, or reduced urine output. In the most advanced, long-standing cases, decades of repeated inflammation in the bladder lining drastically elevate the risk of developing bladder cancer, making urogenital schistosomiasis one of the few known parasitic infections that directly acts as a major carcinogenic risk factor for malignant tumours of the urinary tract.

The impacts of urogenital schistosomiasis extend far beyond the urinary system, creating distinct, often stigmatized symptoms that affect men and women differently. For women, the condition can develop into female genital schistosomiasis, a hidden, underdiagnosed form of the disease that presents with a range of distressing symptoms: persistent genital lesions, unexplained intermenstrual vaginal bleeding, sharp pain during sexual intercourse, and hard, tender nodules that form in the vulva. Women who regularly perform domestic chores in infested water, such as washing clothes at unprotected riverbanks or drawing water from untreated ponds in endemic areas, face drastically higher exposure risks, as repeated skin contact with cercariae-contaminated water builds up chronic infection over years. Most alarmingly, the open, inflamed genital lesions caused by this condition are now widely recognized as a major independent risk factor for HIV infection, as the broken mucosal barrier creates an easy entry point for the virus, making women in schistosomiasis-endemic regions far more vulnerable to HIV transmission than their peers without the infection. For men, urogenital schistosomiasis induces chronic pathology in the seminal vesicles, prostate gland, and other reproductive organs, leading to long-term discomfort, reduced fertility, and persistent urinary symptoms that are often misdiagnosed as common non-parasitic urological conditions.

This wide range of often-overlooked symptoms makes urogenital schistosomiasis a quiet, destructive force that erodes the health, well-being, and livelihoods of millions of people living in endemic communities every year.

Edited by: Secretariat of the Asia-Pacific Network for Drug and Diagnostics Innovation
Produced by: Zheng Qi
Reviewed by: Zhang Haobing
Tel: 021-64377008-2510 Fax: 021-54108329
Address: 207 Ruijin 2nd Road, Huangpu District,Shanghai, P.R. China  Postcode: 200025